Aquifer Material Flashcards
Acute management of unstable angina
- Pharmacology: Heparin, Aspirin, Beta-blocker, Statin, Sublingual nitroglycerin
- Intervention: Non-emergent PCI
“GI cocktail”
Refers to a combination of antacid, viscous lidocaine, and an anticholinergic.
Used for suspected GERD in the hospital setting.
GP IIb/IIIa Inhibitors in Angioplasty for STEMI
In patients undergoing angioplasty, a GP IIb/IIIa inhibitor such as abciximab or eptifibatide inhibits platelet aggregation and may prevent platelet adhesion to the vessel wall.
While these medications increase the risk of bleeding (especially when used in combination with fibrinolytics) and can cause thrombocytopenia within 24 hours of initiation, they improve outcomes in patients with STEMI.
Complications of an MI
-
Chronically:
- Bradyarrhythmia/heart block
- Ventricular arrhythmia
- Reduce ventricular function
- Cardiogenic shock
- Recurrent thrombosis
- 2-7 day window:
- Papillary muscle rupture
- Ventricular free wall rupture
- Pericarditis
-
~Months later:
- Dressler’s syndrome
Standard post-MI discharge drug regimen
- ACE inhibitor
- Beta-blocker
- Aspirin and clopidogrel (dual antiplatelet therapy)
- Statin
- Sublingual nitroglycerin PRN
Why dual antiplatelet therapy for one year after MI?
It has been shown to prevent stent thrombosis, specifically. After the one year, discontinuing is not associated with increased risk of thrombosis.
In what context are ACE inhibitors usually recommended for post-MI hypertension treatment?
New left ventricular systolic dysfunction
Guidelines for afib rate control
- HR <80 BPM is reasonable for symptomatic atrial fibrillation management.
- HR <110 BPM is reasonable if asymptomatic and LVEF is preserved.
Anticoagulation recommendation for patients with afib AND valvular heart disease
Warfarin is the choice over heparin, titrated to an INR between 2 and 3
Otherwise, refer to CHADS-VASc system
Anticoagulation recommendations for patients with afib in the absence of valvular heart disease
If 0, then no need for anticoagulation
If 1, then aspirin for sure, consider DOAC.
If 2 or more, then DOAC or warfarin
Cheynes-Stokes respirations
- aka “periodic breathing”
- Oscillation between apnea and tachypnea
- Stroke, traumatic brain injury, brain tumors, congestive heart failure, or actively dying
Potassium in DKA
Patients with DKA are often hyperkalemic, but potassium deficient!
The hyperkalemia is because the osmolarity forces potassium out of cells, and without intact insulin signaling it is not being siphoned back in.
However, they can’t stop peeing! So they quickly lose all of that potassium, becoming net potassium deficient. So, when you do treat with insulin, the potassium will start going back into cells and the patient will become hypokalemic.
For this reason, potassium must be added to fluids when treating DKA with fluid and insulin. If potassium drops below 3.3, begin IV potassium replacement immediately and delay the insulin treatment until potassium concentration is restored to a normal value
When is it safe to stop an insulin drip on someone being treated for DKA?
When:
- The anion gap is back to normal
- The patient has received long-acting subcutaneous insulin
- The patient can tolerate food PO
Standard tests for a patient newly diagnosed with type II DM
- HbA1c
- Fasting lipids
- Urine albumin/creatinine ratio
Abdominal pain that worsens with movement suggests. . .
. . . focal parietal peritoneal pain
Non-megaloblatsic causes of macrocytosis
- Alcohol use disorder
- Liver disease
- Hypothyroidism
- Hydroxyurea
- Myelodysplasia
- Reticulocytosis
When to consult an abdominal surgeon for explorative surgery in the setting of acute abdomen
- Cholecystitis
- Small bowel obstruction
- Perforation of an abdominal organ
-
Complicated pancreatitis
- ie, impacted gall stone, pancreatic abscess, large or symptomatic pseudocyst, necrotic pancreatitis
Management of acute pancreatitis
- Isotonic IV fluids, pain control, and a soft, low fat diet as tolerated (if there is no vomiting and no ileus).
- Formerly patients with mild pancreatitis were kept NPO for several days until symptoms resolved however more recent trials have shown that a PO diet is safe.